Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters

Alexander Y. Mayorov; Ekaterina O. Koksharova; Ekaterina E. Mishina; Roman V. Drai; Olga I. Avdeeva; Igor E. Makarenko

doi:10.14341/DM9802-7506

For citations:

Mayorov A.Y., Koksharova E.O., Mishina E.E., Drai R.V., Avdeeva O.I., Makarenko I.E. Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters. Diabetes mellitus. 2018;21(6):462-471. https://doi.org/10.14341/DM9802

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy